Tumours with endothelial expression of endocan presented higher number of CD8+ lymphocytes [endothelial endocan positive 1.8 cells/HPF (IQR: 3) vs endothelial endocan negative 1.2 cells/HPF (IQR: 2.4); P = 0.03] and CD68+ macrophages [endothelial endocan positive 9.5 cells/HPF (IQR: 9.8) vs endothelial endocan negative 4.3 cells/HPF (IQR: 9.3); P = 0.01]. This evidence concerns the gene CD68 and neoplasm.